ABSTRACT
Spondyloartritis (SpA) are associated with chronic pain, stiffness and fatique. Also because of having chronic and progressive course, SpA cause greater physical disability and impact negatively health related quality of life in so many ways such as social life and working. And the patients are at increased risk of having psychiatric disorders such as depresion and anxiety. The prevelance of mild depression is 38% and prevelance of moderate depression is 15% in the patients with SpA which are higher than the prevelance rates of depression in the general population. Patients with psoriatic artritis have also a high risk for depression (15%-30%), which appears to be greater than for patients with psoriasis and general population. Being female, having pain, longer duration of disease are the risk factors for depression in SpA. Anxiety symptoms are also seen in SpA patients co-occuring with depression. Sleep problems are associated with SpA because of pain, fatique and severity of disease. Physical disability, pain and sleep problems cause a vicious cycle and decrease the quality of life in SpA. This article will provide an overview of the psychiatric disorders such as depression, anxiety, sleep problems in SpA and negative effects on quality of life.
References
1Dougados M, Baeten D. Spondyloarthritis. Lancet 2011;377:2127-37.
2Garcia-Montoya L, Gul H, Emery P. Recent advances in ankylosing spondylitis: understanding the disease and management. F1000Res 2018;7:F1000.
3Baumberger H, Khan M. Gradual progressive change to equal prevalence of ankylosing spondylitis among males and females in Switzerland: data from the swiss ankylosing spondylitis society (SVMB) [abstract]. Ann Rheum Dis 2017.
4Meesters JJ, Bremander A, Bergman S, Petersson IF, Turkiewicz A, Englund M. The risk for depression in patients with ankylosing spondylitis: a population-based cohort study. Arthritis Res Ther 2014;16:418.
5Zhao S, Thong D, Miller N, et al. The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis. Arthritis Res Ther 2018;20:140.
6Park JS, Jang HD, Hong JY, et al. Impact of ankylosing spondylitis on depression: a nationwide cohort study. Sci Rep 2019;9:6736.
7Hyphantis, T, Kotsis K, Tsifetaki, et al. The relationship between depressive symptoms, illness perceptions and quality of life in ankylosing spondylitis in comparison to rheumatoid arthritis. Clin Rheumatol 2013;32:635-44.
8Amerikan Psikiyatri Birliği. Mental Bozuklukların Tanısal ve Sayımsal El Kitabı. E Köroğlu (Çev. Ed.), beşinci baskı, Ankara: Hekimler Yayın Birliği.
9Kılınç S, Torun F. Türkiye’de klinikte kullanılan depresyon değerlendirme ölçekleri. Dirim Tıp Gazetesi 2011;86:39-47.
10Dikici DS, Ascıbası K, Aydemir Ö. DSM-5 Ölçek Çalışma Grubu. DSM-5 Depresyon Ölçeği Türkçe Formunun geçerliliği ve güvenilirliği Anadolu Psikiyatri Derg 2017;18(Ek sayı 2):51-6.
11Piccinelli M, Wilkinson G. Gender differences in depression. Critical review. Br J Psychiatry 2000;177:486-92.
12Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med 2003;163:2433-45.
13Sheng J, Liu S, Wang Y, Cui R, Zhang X. The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain. Neural Plast 2017:9724371.
14Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31.
15Berk M, Williams LJ, Jacka FN, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 2013;11:200.
16Ertenli İ, Ozer S, Kiraz S, et al. Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level. Rheumatol Int 2012;32:323-30.
17Kopschina Feltes P, Doorduin J, Klein HC, et al. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. J Psychopharmacol 2017;31:1149-65.
18Kang JH, Chen YH, Lin HC. Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population- based study. Ann Rheum Dis 2010;69:1165-8.
19Bremander A, Petersson IF, Bergman S, Englund M. Population-Based Estimates of Common Comorbidities and Cardiovascular Disease in Ankylosing Spondylitis. Arthrit Care Res (Hoboken) 2011;63:550-6.
20Zou Q, Jiang Y, Mu F, Shi Y, Fang Y. Correlation of axial Spondyloarthritis with anxiety and depression. Med Sci Monit 2016;22:3202-8.
21Chan CYY, Tsang HHL, Lau CS, Chung HY. Prevalence of depressive and anxiety disorders and validation of the hospital anxiety and depression scale as a screening tool in axial spondyloarthritis patients. Int J Rheum Dis 2017;20:317-25.
22Kilic G, Kilic E, Ozgocmen S. Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis. Medicine (Baltimore) 2014;93:e337.
23Patel N, Nadkarni A, Cardwell LA, et al. Depression, and Inflammatory Overlap: A Review. Am J Clin Dermatol 2017;18:613-20.
24Kamalaraj N, El-Haddad C, Hay P, Pile K. Systematic review of depression and anxiety in psoriatic arthritis. Int J Rheum Dis 2019;22:967-73.
25Gniadecki R, Robertson D, Molta CT, et al. Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens. J Eur Acad Dermatol Venereol 2012;26:1436-43.
26Wu Z, Fang Y. Comorbidity of depressive and anxiety disorders: challenges in diagnosis and assessment. Shanghai Arch Psychiatry 2014;26:227-31.
27Hakkou J, Rostom S, Mengat M, Aissaoui N, Bahiri R, Hajjaj-Hassouni N. Sleep disturbance in Moroccan patients with ankylosing spondylitis: prevalence and relationships with disease-specific variables, psychological status and quality of life. Rheumatol Int 2013;33:285-90.
28Lee YC, Chibnik LB, Lu B, et al. The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2009;11:R160.
29Meerlo P, Sgoifo A, Suchecki D. Restricted and disrupted sleep: effects on autonomic function, neuroendocrine stress systems and stress responsivity. Sleep Med Rev 2008;12:197-210.
30Jiang Y, Yang M, Lv Q, et al. Prevalence of psychological disorders, sleep disturbance and stressful life events and their relationships with disease parameters in Chinese patients with ankylosing spondylitis. Clin Rheumatol 2018;37:407-14.
31Li Y, Zhang S, Zhu J, Du X, Huang F. Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a case-control study. Arthritis Res Ther 2012;14:R215.
32Karatas G, Bal A, Yuceege M, et al. Evaluation of sleep quality in patients with ankylosing spondylitis and efficacy of anti-TNF-α therapy on sleep problems: A polisomnographic study. Int J Rheum Dis 2018;21:1263-9.
33Karadağ O, Nakas D, Kalyoncu U, Akdoğan A, Kiraz S, Ertenli I. Effect of anti-TNF treatment on sleep problems in ankylosing spondylitis. Rheumatol Int 2012;32:1909-13.
34Da Costa D, Zummer M, Fitzcharles MA. Determinants of sleep problems in patients with spondyloarthropathy. Musculoskeletal Care 2009;7:143-61.
35Nie A, Wang C, Song Y, Xie X, Yang H, Chen H. Prevalence and factors associated with disturbed sleep in outpatients with ankylosing spondylitis. Clin Rheumatol 2018;37:2161-8.
36Leverment S, Clarke E, Wadeley A, Sengupta R. Prevalence and factors associated with disturbed sleep in patients with ankylosing spondylitisand non-radiographic axial spondyloarthritis: a systematic review. Rheumatol Int 2017;37:257-71.
37Gupta MA, Simpson FC, Gupta AK. Psoriasis and sleep disorders: A systematic review. Sleep Med Rev 2016;29:63-75.
38Duffin CK, Wong B, Elizabeth JH, Krueger GG. Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis. J Am Acad Dermatol 2009;60:604-8.
39Krajewska-Włodarczyk M, Owczarczyk-Saczonek A, Placek W. Sleep disorders in patients with psoriatic arthritis and psoriasis. Rheumatologia 2018;56:301-6.
40Gezer O, Batmaz İ, Sariyildiz MA, et al. Sleep quality in patients with psoriatic arthritis. Int J Rheum Dis 2017;20:1212-8.
41Kotsis K, Voulgari PV, Drosos AA, Carvalho AF, Hyphantis T. Health-related quality of life in patients with ankylosing spondylitis: a comprehensive review. Expert Rev Pharmacoecon Outcomes Res 2014;14:857-72.
42Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE. Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky. Curr Rheumatol Rep 2018;20:35.
43Webers C, Essers I, Ramiro S, et al. Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study. Rheumatology (Oxford) 2016;55:419-28.
44Shahlaee A, Mahmoudi M, Nicknam MH, Farhadi E, Fallahi S, Jamshidi AR. Gender differences in Iranian patients with ankylosing spondylitis. Clin Rheumatol 2015;34:285-93.
45Ibn Yacoub Y, Amine B, Laatiris A, Abouqal R, Hajjaj-Hassouni N. Assessment of fatigue in Moroccan patients with ankylosing spondylitis. Clin Rheumatol 2010;29:1295-9.
46Zhao SS, Radner H, Siebert S, et al. Comorbidity burden in axial spondyloartritis: a cluster analysis. Rheumatology (Oxford) 2019;59:690-2.
47Öncülokur N, Keskin D, Garip Y, Bodur H, Köse K. Turkish Version of Evaluation of Ankylosing Spondylitis Quality of Life Questionnaire in Patients With Ankylosing Spondylitis: A Validation and Reliability Study. Arch Rheumatol 2018;33:443-54.
48Bavière W, Deprez X, Houvenagel E, et al. Association between Comorbidities and Quality of Life in Psoriatic Arthritis: Results from a Multicentric Cross-sectional Study (PSAQUAL study). J Rheumatol 2019:181471.
49Kavanaugh A, Gottlieb A, Morita A, et al. The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic artritis: a post hoc analysis of two rondomised controlled studies. Ann Rheum Dis 2019;78:1215-9.
